Internal Medicine, Hematology & Oncology · Stamford, CT
NPI
1093800369
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
34 Shelburne Road
Stamford, CT, 06902
Phone (203) 325-2695
Medicare paid, 2024
$68K
806 services
Medicare patients, 2024
285
Average age 78
Drug cost, 2024
$2.5M
312 prescriptions
Company payments, 2025
$20.65
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael H Bar was code 99214 (office e&m - established), 433 times for 200 patients. In total Michael H Bar billed 806 services in 8 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-12-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 433 | 200 | $67.92 | $29K |
| 99215 Office E&M - Established | Facility | 192 | 98 | $103.98 | $20K |
| 99205 Office E&M - New | Facility | 47 | 47 | $127.83 | $6,008 |
| 99233 Hospital E&M - Subsequent | Facility | 44 | 21 | $90.83 | $3,996 |
| 99223 Hospital E&M - Initial | Facility | 38 | 34 | $130.35 | $4,953 |
| 99232 Hospital E&M - Subsequent | Facility | 37 | 25 | $60.45 | $2,237 |
By year: 2022 $94K for 1,021 services; 2023 $77K for 892 services; 2024 $68K for 806 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael H Bar prescribed most often to Medicare patients was Imbruvica (Ibrutinib), with 63 prescriptions and refills. In total Michael H Bar wrote 312 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imbruvica Ibrutinib | 63 | 63 | Under 11 | $927K |
| Venclexta Venetoclax | 62 | 62 | Under 11 | $708K |
| Hydroxyurea Generic | 55 | 119 | 15 | $1,408 |
| Brukinsa Zanubrutinib | 25 | 25 | Under 11 | $345K |
| Promacta Eltrombopag Olamine | 18 | 18 | Under 11 | $187K |
| Xarelto Rivaroxaban | 12 | 16 | Under 11 | $8,908 |
| Deferiprone Generic | 11 | 11 | Under 11 | $86K |
Brand drugs: 202 claims; generic drugs: 110 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael H Bar $20.65 ($20.65 in general payments such as food, travel and fees) from 2 companies. The largest payer was GlaxoSmithKline, LLC. with $20.65.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 1 | $20.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.